Roeland E. Wasmann
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
Papers in
-
- HIV/AIDS drug development and treatment 16
- Antifungal resistance and susceptibility 8
- Tuberculosis Research and Epidemiology 4
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- Roger J. M. BrüggemannCatherijne A. J. KnibbeDavid M. BurgerCornelis SmitPaul E. VerweijPaolo DentiEline W. MuilwijkEric P.A. van Dongen
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)British Journal of Clinical Pharmacology (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)Clinical Infectious Diseases (3 papers)Clinical Pharmacokinetics (3 papers)
- Partner nations
- South AfricaNetherlandsUnited States
In The Last Decade
Roeland E. Wasmann
35 papers receiving 399 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 230
- Applied Microbiology and Biotechnology 23
- Pharmacology 166
- Pediatrics, Perinatology and Child Health 78
- Virology 18
Countries citing papers authored by Roeland E. Wasmann
This map shows the geographic impact of Roeland E. Wasmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roeland E. Wasmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roeland E. Wasmann more than expected).
Fields of papers citing papers by Roeland E. Wasmann
This network shows the impact of papers produced by Roeland E. Wasmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roeland E. Wasmann. The network helps show where Roeland E. Wasmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Roeland E. Wasmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 18 | |
| 15 | 2020 | 22 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 19 | |
| 18 | 2019 | 37 | |
| 19 | 2019 | 22 | |
| 20 | 2018 | 30 |
About Roeland E. Wasmann
Roeland E. Wasmann is a scholar working on Infectious Diseases, Virology, Family Practice, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 40 papers that have together received 403 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), Antifungal resistance and susceptibility (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), HIV Research and Treatment (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), Pharmaceutical studies and practices (5 papers), Tuberculosis Research and Epidemiology (4 papers) and HIV-related health complications and treatments (3 papers). The work is most often cited by research in Infectious Diseases (230 citations), Applied Microbiology and Biotechnology (23 citations), Pharmacology (166 citations), Pediatrics, Perinatology and Child Health (78 citations) and Virology (18 citations). Roeland E. Wasmann has collaborated with scholars based in South Africa, Netherlands and United States. Frequent co-authors include Roger J. M. Brüggemann, Catherijne A. J. Knibbe, David M. Burger, Cornelis Smit, Paul E. Verweij, Paolo Denti, Eline W. Muilwijk, Eric P.A. van Dongen, Johan W. Mouton and Rob ter Heine. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, British Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.